Nanoparticles containing anti-cancer drug – A review

Authors

  • Sravya Sree Konda Ratnam Institute of Pharmacy, Pidathapolur Village and Post, Muthukur (M), SPSR Nellore, Andhra Pradesh 524346 https://orcid.org/0009-0004-9893-9151
  • Ramesh Yerikala Department of Pharmaceutics, Ratnam Institute of Pharmacy, Pidathapolur Village and Post, Muthukur (M), SPSR Nellore, Andhra Pradesh 524346 https://orcid.org/0000-0002-8331-8190
  • Venugopalaiah P Department of Pharmaceutics, Ratnam Institute of Pharmacy, Pidathapolur Village and Post, Muthukur (M), SPSR Nellore, Andhra Pradesh 524346 https://orcid.org/0009-0000-8113-5414
  • Prapurna Chandra Y Department of Pharmacology, Ratnam Institute of Pharmacy, Pidathapolur Village and Post, Muthukur (M), SPSR Nellore, Andhra Pradesh 524346

DOI:

https://doi.org/10.26452/ijcpms.v3i4.558

Keywords:

Nanoparticles, Anti-Cancer, Paclitaxel, Melanoma

Abstract

These day throughout medicine and science as well as investigates, melanoma is among the most threating illness even though sadly now still we've neither medical care regarding purchasing of this illness. There have been multiple strategies regarding cancer therapy utilizing nanoparticles such as targeted as well as non-targeted nanoparticles. Various studies demonstrate that adverse reactions like doxorubicin (an anti - cancer drug) could be reducing through nanotechnology, that also decrease this same multi - drug resistant. Camptothecin loaded Nanoparticles demonstrate prolonged plasma retention, elevated as well as prolonged tumour location. Nano-particles ready besides poly-lactic-co-glycoside rise a half-life of cisplatin. Recent innovation through Nanoparticle-based common therapeutic have also shown some many distinguishing characteristics which are unworkable out conventional chemotherapy. Drug mixtures can be optimized and cunningly presented in this more wise investment.

Downloads

Download data is not yet available.

Downloads

Published

2024-01-20

How to Cite

Konda , S. S., Yerikala, R., P, V., & Y, P. C. (2024). Nanoparticles containing anti-cancer drug – A review. International Journal of Clinical Pharmacokinetics and Medical Sciences, 3(4), 124–135. https://doi.org/10.26452/ijcpms.v3i4.558

Issue

Section

Review Article